| Pharmaceutical Information |
| Drug Name |
Cinoxacin |
| Drug ID |
BADD_D00470 |
| Description |
Synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections. |
| Indications and Usage |
For the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: Escherichia coli, Proteus mirabilis, Proteus vulgaris, Klebsiella species (including K. pneumoniae), and Enterobacter species. |
| Marketing Status |
Discontinued |
| ATC Code |
J01MB06 |
| DrugBank ID |
DB00827
|
| KEGG ID |
D00872
|
| MeSH ID |
D002937
|
| PubChem ID |
2762
|
| TTD Drug ID |
D07UXP
|
| NDC Product Code |
Not Available |
| Synonyms |
Cinoxacin | Clinoxacin | Azolinic Acid | Acid, Azolinic | Compound 64716 | Cinobac |
|
| Chemical Information |
| Molecular Formula |
C12H10N2O5 |
| CAS Registry Number |
28657-80-9 |
| SMILES |
CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
